Literature DB >> 27141077

Advanced ovarian cancer: 20 years of ovarian cancer treatment.

A Poveda1, I Romero2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27141077     DOI： 10.1093/annonc/mdw081

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.

Authors:  Chencheng Dai; Pengfei Xu; Siyu Liu; Sujuan Xu; Juan Xu; Ziyi Fu; Jian Cao; Mingming Lv; Juan Zhou; Guangquan Liu; Huilin Zhang; Xuemei Jia
Journal:  Arch Gynecol Obstet       Date:  2020-11-05       Impact factor: 2.344

2.  Integrated glycomic analysis of ovarian cancer side population cells.

Authors:  Ran Zhao; Xiaoxia Liu; Congjian Xu; Shifang Ren; Yisheng Wang; Xiaoxiang Jie; Ruihuan Qin; Wenjun Qin; Mengyu Zhang; Haiyan Tai; Caiting Yang; Lili Li; Peike Peng; Miaomiao Shao; Xingwang Zhang; Hao Wu; Yuanyuan Ruan; Jianxin Gu
Journal:  Clin Proteomics       Date:  2016-11-10       Impact factor: 3.988

3.  Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp.

Authors:  Yisheng Wang; Congjian Xu; Ran Zhao; Wenjun Qin; Ruihuan Qin; Jing Han; Can Li
Journal:  Clin Proteomics       Date:  2017-05-23       Impact factor: 3.988

4.  BRCA1 Expression by Immunohistochemistry and Prognosis in Ovarian Cancer: A Systematic Review and Meta-Analysis.

Authors:  Lorena Alves Teixeira; Francisco Jose Candido Dos Reis
Journal:  Target Oncol       Date:  2020-02       Impact factor: 4.864
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.